Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Maddaluno, Marcella ^a   Grassia, Gianluca ^a   Di Lauro, Maria Vittoria ^a   Parisi, Antonio ^a   Maione, Francesco ^a   Cicala, Carla ^a   De Filippis, Daniele ^a   Iuvone, Teresa ^a   Guglielmotti, Angelo ^b   Maffia, Pasquale ^a,c   Mascolo, Nicola ^a   Ialenti, Armando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BINDARIT; CALPONIN; CONTRACTILE PROTEIN; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYOSIN HEAVY CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SWITCHING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MORPHOMETRICS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHENOTYPIC SWITCHING; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ACTINS; ANIMALS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CORONARY VESSELS; GENE EXPRESSION; HUMANS; INDAZOLES; MICROFILAMENT PROTEINS; MONOCYTE CHEMOATTRACTANT PROTEINS; MYOCYTES, SMOOTH MUSCLE; MYOSIN HEAVY CHAINS; NEOINTIMA; PROPIONATES; RATS;

EID: 84867569419     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047464     Document Type: Article

References (27)

1. Marx SO, Totary-Jain H, Marks AR, (2011) Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4: 104-111.
2. Owens GK, Kumar MS, Wamhoff BR, (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
3. Regan CP, Adam PJ, Madsen CS, Owens GK, (2000) Molecular mechanisms of decreased smooth muscle differentiation marker expression after balloon injury. J Clin Invest 106: 1139-1147.
4. Charey DJ, (1991) Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 53: 161-177.
5. Schober A, (2008) Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28: 1950-1959.
6. Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, et al. (2004) Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res. 95: 1125-33.
7. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, et al. (2002) Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 283: H1455-H1461.
8. Parenti A, Bellik L, Brogelli L, Filippi S, Ledda F, (2004) Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 286: H1978-84.
9. Denger S, Jahn L, Wende P, Watson L, Gerber SH, et al. (1999) Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to VSMC differentiation in the process of atherogenesis. Atherosclerosis 144: 15-23.
10. Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, et al. (2008) Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw 19: 119-22.
11. Mora E, Guglielmotti A, Biondi G, Sassone-Corsi P, (2012) Bindarit: an anti-inflammatory small molecule that modulates the NFκB pathway. Cell Cycle 11: 159-69.
12. Perico N, Benigni A, Remuzzi G, (2008) Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 7: 936-853.
13. Rulli NE, Guglielmotti A, Mangano G, Rolph MS, Apicella C, et al. (2009) Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum 60: 2513-2523.
14. Bhatia M, Devi Ramnath RD, Chevali L, Guglielmotti A, (2005) Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am JPhysiol Gastrointest Liver Physiol 288: G1259-G1265.
15. Bhatia M, Landolfi C, Basta F, Bovi G, Ramnath RD, et al. (2008) Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis. Inflamm Res 57: 464-471.
16. Grassia G, Maddaluno M, Guglielmotti A, Mangano G, Biondi G, et al. (2009) The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice. Cardiovasc Res 84: 485-93.
17. Ialenti A, Grassia G, Gordon P, Maddaluno M, Di Lauro MV, et al. (2011) Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries. Arterioscler Thromb Vasc Biol 31: 2448-54.
18. Colombo A, Limbruno U, Lettieri C, Lioy E, Guglielmotti A, et al. (2012) A double blind randomized study to evaluate the efficacy of bindarit in preventing coronary stent restenosis. J Am Coll Cardiol. 59: E11-E11.
19. Maddaluno M, DiLauro MV, Di Pascale A, Santamaria R, Guglielmotti A, et al. (2011) Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis 217: 113-9.
20. Grassia G, Maddaluno M, Musilli C, De Stefano D, Carnuccio R, et al. (2010) The IκB kinase inhibitor nuclear factor-κB essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 30: 2458-66.
21. Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, et al. (2006) Neutralization of Interleukin-18 Inhibits Neointimal Formation in a Rat Model of Vascular Injury. Circulation 114: 430-437.
22. Alexander MR, Owens GK, (2012) Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 74: 13-40.
23. Indolfi C, Cioppa A, Stabile E, Di Lorenzo E, Esposito G, et al. (2000) Effects of hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 35: 214-21.
24. Martin KA, Merenick BL, Ding M, Fetalvero KM, Rzucidlo EM, et al. (2007) Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/akt2 feedback signaling. J Biol Chem 282: 36112-36120.
25. Wada H, Abe M, Ono K, Morimoto T, Kawamura T, et al. (2008) Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Biochem Biophys Res Commun 374: 731-736.
26. Newby AC, Zaltsman AB, (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309.
27. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA, (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75: 539-545.